CORTIMENT VS. PREDNISOLONE: A PROFOUND REDUCTION IN THE INCIDENCE OF SIDE EFFECTS AND IMPACT ON DAILY LIFE2
Data gathered from observational analysis
Adverse Event reporting information can be found in footer
Request a Meeting
CORTIMENT VS. PREDNISOLONE: A PROFOUND REDUCTION IN THE INCIDENCE OF SIDE EFFECTS AND IMPACT ON DAILY LIFE2
Data gathered from observational analysis
| Prednisolone | CORTIMENT | |
|---|---|---|
| % of patients who experienced ≥1 adverse events during treatment |
79%(n=22) | 21% (n=6) |
| % of patients who experienced moderate to severe impact on daily life |
46% (n=13) | 7% (n=2) |
9mg CORTIMENT® tablet
Data from the UK Real World Evidence study supports the safety profile of CORTIMENT reported in the international Real World Evidence study (24.1% (n=84) of patients reported ≥1 adverse event).1,2
Results from an observational analysis evaluating the tolerability and ease of administration of CORTIMENT for the treatment of active mild to moderate UC at a local level2
Job Code: UK-COR-2100003 - Date of preparation: April 2021
